Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?

Novel drugs have improved survival for patients with multiple myeloma in recent years. However, the disease is still fatal. Allogeneic stem cell transplantation (Allo) has proven to cure some patients with the disease, but its role is controversial due to relatively high transplant-related toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahrton, Gösta, Iacobelli, Simona, Garderet, Laurent, Yakoub-Agha, Ibrahim, Schönland, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408931/
https://www.ncbi.nlm.nih.gov/pubmed/32664274
http://dx.doi.org/10.3390/jcm9072180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408931/
https://www.ncbi.nlm.nih.gov/pubmed/32664274
http://dx.doi.org/10.3390/jcm9072180

Ejemplares similares